https://specialty.mims.com/topic/add-on-reslizumab-cuts-exacerbations--ocs-use-in-severe-eosinophilic-asthma
0
0
Add-on reslizumab cuts exacerbations, OCS use in severe eosinophilic asthma | Latest news for Doctors, Nurses and Pharmacists | Respirology - MIMS
9/27/22 at 2:00am
Organization
Mims.com
Author
Audrey Abella
Details
41 words
Summarize
Respiratory Conditions Health Drugs & Medications reslizumab cuts interleukin asthma exacerbation rate Pharmacists | Respirology - MIMS Reslizumab corticosteroid
Reslizumab, a biologic targeting interleukin(IL)-5, reduced severe asthma exacerbation rate and oral corticosteroid (OCS) use in individuals with seve...
Create an account or login to join the discussion